MARKET PULSE-YRC Worldwide, Intercept, Chelsea, Target, Bazaarvoice
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures trimmed gains on Friday after the December nonfarm payroll report came in sharply below expectations. Dow Jones industrial average futures were up 0.13 percent at 16,413, S&P 500 futures were up 0.19 percent at 1,836.5 and Nasdaq 100 futures were up 0.25 percent at 3,556.5.
** YRC WORLDWIDE INC, Thursday close $15.67, -18.95 pct premarket
Workers at the trucking company represented by the Teamsters union rejected a contract extension that the company proposed, putting a plan to restructure its debt in jeopardy.
** INTERCEPT PHARMACEUTICALS INC Thursday close $275.87, +31.94 pct premarket
** CONATUS PHARMACEUTICALS INC Thursday close $9.8, +28.88 pct premarket
Intercept's shares nearly quadrupled to a life high of $305 on Thursday after the company's drug to treat liver disease caused by fat buildup was found effective in a trial, paving the way for it to become the first approved treatment for the chronic condition.
At least three brokerages - Citigroup, Needham and Oppenheimer - raised their price targets on the stock on Friday. Shares of biotechnology company Conatus, which is focused on the treatment of liver disease, also jumped on the news. Continued...